60Nd: Funding, Investors & Team (Sep 2026)
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with NeoMag, the first magneto-mechanical platform designed to simulate real pathological processes on biological systems. By combining smart materials with AI-driven models, we induce precise, non-invasive mechanical forces directly onto cells. NeoMag bridges the gap between the lab bench and living tissue, accelerating drug discovery and significantly reducing the need for animal testing. Our US/EU patented tech, tested in word class labs like Institut Pasteur or Imperial College, uses AI and smart materials to apply precise 2D/3D forces. Backed by prestigious programas like EIC Transition, and an award-winning scientific team, we provide ultra-predictive models that accelerate drug discovery to Pharmas and Biotechs in fields like cancer, derma or neuro.
60Nd has raised $2.9M across 1 funding round on record, the most recent an undisclosed round of $2.9M announced in Feb 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
60Nd Company Profile and Key Stats
Latest funding round on record: Feb 2026.
60Nd Funding Rounds
60Nd Founders and Leadership Team
No contact details are on record for this team yet.
60Nd Funding Compared to Other Biotechnology Startups
60Nd's latest round of $2.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like 60Nd in Biotechnology and Madrid
Companies Similar to 60Nd
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Highlight Therapeutics is a private, clinical-stage company dedicated to unlocking the full potential of…
60Nd Funding FAQs
What does 60Nd do?
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with NeoMag, the first magneto-mechanical platform designed to simulate real pathological processes on biological systems. By combining smart materials with AI-driven models, we induce precise, non-invasive mechanical forces directly onto cells. NeoMag bridges the gap between the lab bench and living tissue, accelerating drug discovery and significantly reducing the need for animal testing. Our US/EU patented tech, tested in word class labs like Institut Pasteur or Imperial College, uses AI and smart materials to apply precise 2D/3D forces. Backed by prestigious programas like EIC Transition, and an award-winning scientific team, we provide ultra-predictive models that accelerate drug discovery to Pharmas and Biotechs in fields like cancer, derma or neuro.
How much funding has 60Nd raised?
60Nd has raised $2.9M across 1 round on record. The most recent is an undisclosed round of $2.9M announced in Feb 2026.
When did 60Nd last raise funding?
60Nd's most recent funding round on record is an undisclosed round of $2.9M, announced in Feb 2026.
Who founded 60Nd?
FundedIQ lists Ricardo De La Torre Gonzalez (Founder) at 60Nd.
Where is 60Nd headquartered?
60Nd is based in Madrid, Madrid, Spain.
How many employees does 60Nd have?
60Nd is in the 1-10 employee band.
How does 60Nd's funding compare to other Biotechnology startups?
60Nd's latest round of $2.9M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's 60Nd Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 60Nd is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.